Autoreactive T cell clones of MHC class II specificities are produced during responses against foreign antigens in man.

A F Tilkin(Centre National de la Recherche Scientifique), Joshua Levy(Centre National de la Recherche Scientifique), Dominique Juy(Centre National de la Recherche Scientifique), Yvette Hénin(Centre National de la Recherche Scientifique), Ghislaine Sterkers(Délégation Paris 7), Michèle Kayibanda(Centre National de la Recherche Scientifique), H Bétuel(Hôpital Cochin), Jean Michon(Université Paris Sciences et Lettres)
The Journal of Immunology
February 1, 1987
10.4049/jimmunol.138.3.674
Cited by 47

Related Papers

Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations
|Nature Genetics|2015|563
Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients
|Blood|2006|431
Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents
|Blood|2006|362
Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study
|The Lancet Oncology|2009|196
CARD15/NOD2 Is Required for Peyer's Patches Homeostasis in Mice
|PLoS ONE|2007|139